PR Newswire

The Bulletin

Men's Weekly

.

YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection

Written by PR Newswire

YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection

GAITHERSBURG, Md., Sept. 15, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the...

How Headless CMS Supports High-Traffic Event-Driven Websites

Why Structured Content Is the Core Advantage of Headless CMS

Services Lawyers in Brisbane Can Provide for Growing Businesses

What to Expect When Working with Lawyers in Sydney for the First Time

Dentist Bundoora Providing Trusted Local Dental Care for Every Stage of Life

CoolSculpting Melbourne for Non-Invasive Fat Reduction and Body Contouring

The Gold Standard: A Definitive Guide to Australian Oral Care

Self Managed Super Fund Setup for Greater Control and Smarter Retirement Planning

Designing an Outdoor Space You’ll Actually Use

7 Best New Home Inspectors in Melbourne (2026 Guide)

Exploring Australia’s Best Food Scenes Outside Major Cities

DVO (FrontRunner)– Rooftop Tents: The Ultimate Guide for Adventure Enthusiasts